The following sessions are of interest to surgeons and anesthesiologists.

Surgery Track Brochure
View the 2010 mailer with page-turning technology.
View Brochure

Program Planner: Browse or search sessions, presentations or speakers.

Track-At-A-Glance (pdf)

Surgery Track Programming
Select a day below to view programming for the Surgery Track.

Saturday 

Sunday 

Monday

Tuesday 

Wednesday

Saturday, Nov. 13
1-2:15 p.m.       
Aortic Valve Treatment: Changing Paradigms in Diagnosis and Approach

• Epidemiology and Pathophysiology of Aortic Stenosis
• Controversies in Diagnostic Testing and Indications for Valve Replacement
• Open Aortic Valve Replacement -- Still the Gold Standard
• Patient-Prosthesis Mismatch: Does It Matter?
• Percutaneous Aortic Valves: Which Valve for Which Patient?
• Case Study: Percutaneous Challenges in AVR

Sunday, Nov. 14
8-11 a.m.
Coronary Artery Bypass Innovations

• All-Arterial Revascularization
• MIDCAB Advances
• Hybrid Combined CABG with PCI
• Current Status of Robotic TECAB
• On-Pump CABG Is Still the Gold Standard
• Off-Pump CABG Is the Platinum Standard in Japan
• Veins Used Correctly Are Still Great Conduits
• Molecular and Cellular Therapies for Enhancing Vein Graft Patency

5:30-6:45 p.m. 
Grantsmanship Workshop

• NIH "Insider" Insights
• NIH R01: Specific Aims, Background and Preliminary Data
• NIH R01: Experimental Design
• Career Development Awards
• Foundation Grants

5:30-6:45 p.m.
VAD Implantation Tips and Tricks

• Extracorporeal Devices
• Axial Flow Devices
• Implantable Rotary Devices
• Animal Models of Ventricular Assist Research
• Novel Cellular Linings for VADs

Monday, Nov. 15
7:45-8:45 a.m.    
Atrial Fibrillation Surgery
How to Maximally Utilize Intraoperative TEE

• TEE-Guided Complex Valve Repair
• Applications for TEE While on Cardiopulmonary Bypass
• 3D TEE Utility in Extremely Challenging Cases

5:30-6:45 p.m.
Transcatheter Valve Therapies

• AVR Transfemoral Approach
• AVR Transapical Approach
• Transcatheter Mitral Repair Devices
• Transcatheter Mitral Valve Replacement
• Computational Fluid Dynamics Considerations

5:30-6:45 p.m.
Heparin-Induced Thrombocytopenia: New Concepts and New Anticoagulants

• New Concepts About Pathophysiology
• Patients at Risk: Interpreting HIT Tests
• Implications of Thrombocytopenia in Cardiovascular Disease
• Intraoperative Strategies for the HIT Patient
• Postoperative Management: Current Strategies

Tuesday, Nov. 16
7:45-8:45 a.m.
Contemporary Strategies for Complex Univentricular Congenital Lesions
How to Optimally Repair the Degenerative Mitral Valve

• Leaflet Resection
• Leaflet Preservation and Imbrication
• Neochordal Construction

9-10:15 a.m. 
Enhancing Stem Cell Therapy

5:30-6:45 p.m.
Thoracic Aortic Surgery Advances

• When to Replace the Ascending Aorta in Bicuspid Aortic Valve Disease
• Endograft Stenting of the Descending Aorta During Operative Type A Dissection Repair
• TAAA Repair: What Have We Learned After 2000 Cases?
• Extreme Hybrid Arch and TAAA Endografting
• Neuroprotection Advances

5:30-6:45 p.m. 
Young Cardiovascular Surgeons and Anesthesiologists Committee Forum                                     

• Classic Training Pathway
• Alternate Training Pathways: Fast-Track and Integrated
• Starting Out: Operate Like Crazy
• Starting Out: Secure a Grant
• Managing Industry Relationships

Wednesday, Nov. 17
7:45-8:45 a.m.
How to Repair the Aortic Valve

• Valve-Sparing Aortic Root Replacement
• Leaflet Repair
• Repairing the Bicuspid Aortic Valve

2-3:15 p.m.
Heart Failure: Emerging Imaging Modalities, Strategies and Therapies

• Multimodality Imaging to Identify the Optimal Therapy (Revascularization, Remodeling, Replacement)
• Emerging Concepts in Cardiac Tissue Engineering
• Catheter-Based Stem Cell Therapy for the Failing Heart: Where Are We Going?
• Cutting Edge Surgery for the Failing Heart: A New STITCH or Jacket?
• Novel VAD Technology, Implantable RVAD and the Next Total Artificial Heart